<DOC>
	<DOC>NCT02161146</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of AGN-229666 for the prevention of allergen-mediated conjunctivitis.</brief_summary>
	<brief_title>AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Allergic</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>Japanese patients living in Japan with a history of allergic conjunctivitis. Presence of active eye infection (bacterial, viral, or fungal) History of an eye herpetic infection.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>